Healthcare -
Biotechnology - NASDAQ - US
$ 1.2192
7.04 %
$ 3.61 M
Market Cap
-0.12
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Pasithea Therapeutics Corp.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 13.6 M |
| Operating Income | -14.2 B |
| Other Expenses | -14.2 B |
| Net Income | -13.9 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0.5 | 15.1 K | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0 | 0.6 | 0.1 | 17.3 K | 0 |
| Gross Profit | 0 | (0.6) | 0.4 | 2.21 K | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 13.6 | 16.0 | 15.2 | 4.5 | 41 K |
| Selling, General and Administrative Expenses | 7 051.5 | 7.9 | 12.5 | 4.5 | 41 K |
| Research and Development Expenses | 7 198.5 | 8.1 | 2.7 | 0 | 0 |
| Operating Income | (14 250.0) | (16.0) | (14.8) | (4.5) | 41 K |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 0 | 102 | 508 | 0 |
| Total Other Income | 345.4 | 0.5 | 0.9 | 2.3 | 4 |
| Pre-Tax Income | (13 904.6) | (15.5) | (13.9) | (2.2) | 41 K |
| NET INCOME | |||||
| Tax Provision | 0 | 0 | (0.9) | 508 | 61.5 K |
| Net Income | (13 904.6) | (16.0) | (13.1) | (2.2) | 41 K |
| EPS | 12.7 K | 12.7 | 10.3 | 1.89 | 0.0595 |